Author:
Akkoç Nurullah,Arteaga Carlos H.,Auteri Simone E.,Betts Marissa,Fahrbach Kyle,Kim Mindy,Kiri Sandeep,Neupane Binod,Gaffney Karl,Mease Philip J.
Publisher
Springer Science and Business Media LLC
Subject
Immunology and Allergy,Rheumatology
Reference42 articles.
1. Robinson PC, Sengupta R, Siebert S. Non-radiographic axial spondyloarthritis (nr-axSpA): advances in classification, imaging and therapy. Rheumatol Therapy. 2019;6:165–77.
2. de Winter JJ, van Mens LJ, van der Heijde D, Landewé R, Baeten DL. Prevalence of peripheral and extra-articular disease in ankylosing spondylitis versus non-radiographic axial spondyloarthritis: a meta-analysis. Arthritis Res Ther. 2016;18:1–11.
3. van der Meer R, Arends S, Kruidhof S, et al. Extraskeletal manifestations in axial spondyloarthritis are associated with worse clinical outcomes despite the use of tumor necrosis factor inhibitor therapy. J Rheumatol. 2021;2:2.
4. Hunter T, Sandoval D, Booth N, Holdsworth E, Deodhar A. Comparing symptoms, treatment patterns, and quality of life of ankylosing spondylitis and non-radiographic axial spondyloarthritis patients in the USA: findings from a patient and rheumatologist Survey. Clin Rheumatol. 2021;40:3161–7.
5. Mease PJ, Heijde DV, Karki C, et al. Characterization of patients with ankylosing spondylitis and nonradiographic axial spondyloarthritis in the US-based corrona registry. Arthritis Care Res (Hoboken). 2018;70:1661–70.